Subacute toxicity of mesoporous silica nanoparticles to the intestinal tract and the underlying mechanism

Yu-Di Deng,Xu-Dong Zhang,Xu-Shan Yang,Zhen-Lie Huang,Xi Wei,Xing-Fen Yang,Wen-Zhen Liao

DOI: https://doi.org/10.1016/j.jhazmat.2020.124502

IF: 13.6

2021-05-01

Journal of Hazardous Materials

Abstract:The biological safety of mesoporous silica nanoparticles (MSNs) has gradually attracted attention. However, few studies of their toxicity to the intestine and mechanism are available. In this study, their primary structures were characterized, and their subacute toxicity to mice was investigated. After 2 weeks of intragastric administration of MSNs, they significantly enhanced serum ALP, ALT, AST and TNF-α levels and caused infiltration of inflammatory cells in the spleen and intestines. MSNs induced intestinal oxidative stress and colonic epithelial cell apoptosis in mice. Intestinal epithelial cells exhibited mitochondrial ridge rupture and membrane potential decrease after MSN treatment. Additionally, MSNs increased ROS and NLRP3 levels and inhibited expression of the autophagy proteins LC3-II and Beclin1. MSNs significantly changed the intestinal flora diversity in mice, especially for harmful bacteria, leading to intestinal microecology imbalance. Meanwhile, MSNs influenced the expression of metabolites, which were involved in a range of metabolic pathways, including pyrimidine metabolism, central carbon metabolism in cancer, protein digestion and absorption, mineral absorption, ABC transport and purine metabolism. These results indicated that the subacute toxicity of mesoporous silicon was mainly caused by intestinal damage. Thus, our research provides additional evidence about the safe dosage of MSNs in the clinical and food industries.

environmental sciences,engineering, environmental

What problem does this paper attempt to address?

The problem this paper attempts to address is the subacute toxicity of Mesoporous Silica Nanoparticles (MSNs) on the intestine and its potential mechanisms. Although MSNs show broad application prospects in many fields, research on their effects and mechanisms on the intestine is relatively scarce. Therefore, this study aims to fill this knowledge gap by evaluating the subacute toxic effects of MSNs on the intestines of mice, exploring their impact on the gut microbiota, metabolomics, and apoptosis, thereby providing a theoretical basis for the safe application of MSNs in clinical and food industries.

Specifically, the researchers focused on the following aspects:
1. **Subacute Toxicity Assessment**: Evaluating the effects of different doses of MSNs on the major organs (especially the intestines) of mice through continuous oral administration for 14 days.
2. **Pathological Changes**: Observing the pathological changes in intestinal tissues caused by MSNs, including inflammatory cell infiltration, oxidative stress, and apoptosis of colonic epithelial cells.
3. **Cellular Level Effects**: Detecting the effects of MSNs on the mitochondrial structure, membrane potential, and expression of autophagy-related proteins in intestinal epithelial cells.
4. **Microbial Community Changes**: Analyzing the impact of MSNs on the diversity and composition of the gut microbiota in mice, particularly the changes in harmful bacterial populations.
5. **Metabolomics Analysis**: Investigating the effects of MSNs on intestinal metabolites, including changes in metabolites involved in various metabolic pathways.

Through these studies, the authors hope to provide more evidence for the safe dosage of MSNs and offer guidance for future applications.